BRIGHTON BIOTECH - Key Persons
Job Titles:
- Member of the Advisory Committee
Dr. Barley's medical career has been dedicated to addressing both the concerns of his individual patients and, at the same time, the political issues and causes that describe the nature of medical care in our society and throughout the world.
Dr. Barley is a Diplomat of the American Board of Internal Medicine, and has been in the private practice of General Medicine since 1996. Dr. Barley is a member of the Independent Doctors of NY (IDNY).
Additionally, as a participating physician in both Corporate Care and The Executive Registry at New York Presbyterian Hospital, he is part of an international network of physicians and hospitals that facilitate high level care throughout the world through referrals and emergency intervention. As vice-president of Citta, a not for profit organization with hospitals in India, Nepal, and Mexico, he has overseen the delivery of health care to underserved communities in the Third World.
Dr. Floyd has over 20 years of clinical research experience.
Most recently he was the Executive Vice President and Chief Scientific Officer of Pharmacopeia, Inc., a US based corporation that was later acquired by Ligand.
He consulted extensively and was a member of several scientific advisory boards including ARYx, Redpoint Pharmaceuticals, Kalypsys, Medicines for Malaria Venture (MMV), Gentara, ExSAR, Millenium, and others
Previously Dr. Floyd worked at Bristol-Myers Squibb (BMS), first as a Research Investigator in the Department of Organic Chemistry, and through the years progressed through several roles of increasing responsibility. He spent more than 10 years as Vice President, Discovery Chemistry, at the BMS Pharmaceutical Research Institute.
Dr. Floyd started his pharmaceutical career as a Junior Chemist in Organic Chemistry at Alza Corporation in Palo Alto, California and subsequently earned a Ph.D. in Organic Chemistry from the University of Michigan followed by 2 years as an NIH Postdoctoral Fellow at Harvard University with Professor E. J. Corey.
Job Titles:
- Member of the Advisory Committee
Mr. Taylor lives in London, England. He is Chairman of Living PlanIT SA which is developing an open standards software operating system for urban areas, connecting devices, sensors and infrastructure. Also Chairman of the Rainbow Seed Fund Advisory Board: the Fund invests on behalf of leading British publicly funded research organizations to kick-start ventures emerging from the UK science research base.
Mr. Taylor chairs the UK National Space Academy steering group, a network of teachers and project scientists inspiring learning through the context of space. He is a member of the UK Science and Technology Facilities Council which inter alia supports physics and astronomy research and access to large-scale scientific infrastructures and analytical facilities. He is chair of the Development Committee of the British Society for Research on Ageing.
Mr. Taylor was for 23 years a British Member of Parliament and was UK government Science Minister from 1994 - 97. In Parliament, Mr. Taylor chaired the all-Party Parliamentary & Scientific Committee which includes the Parliamentary Engineering Group. He was Chairman of the Space Committee. He sat on the Commission on National Security during the period 2007 - 2009.
Prior to entering Parliament in 1987, Mr. Taylor had 18 years' experience in providing corporate finance and management advice to companies in the UK, France and the USA.
Job Titles:
- Member of the Board of Directors
Admiral Hogg departed public service in 2013, having served for 18 years as Director of the Chief of Naval Operations' Strategic Studies Group, which he transformed from strategic studies to a research center with the mission to generate future war-fighting concepts at the Operational level of warfare. Earlier he served for four years as President of the National Security Industrial Association, a major national defense industry association of some 400 companies of all sizes from all segments of industry that relate to U.S. national security.
His Staff service included assignment as Executive Assistant to the Chief of Naval Personnel, Director of Military Personnel Policy, and Director of Naval Warfare working in the areas of military requirements and acquisition.
Before retirement from the Navy in May 1991, he served three years as the U.S. Representative to the NATO Military Committee, gaining comprehensive experience at the highest levels of political/military planning and policy development.
While on active duty he was awarded the Distinguished Service Medal (three), the Legion of Merit (three) and other U .S. and foreign decorations. He has received the Vice Admiral Charles E. Weakley Award (1989), the Betsy Ross Freedom Award (1991), and the Roland M. Teel Award (1995).
Admiral Hogg graduated from the Naval Academy and was commissioned in the Navy in June 1956. He served for thirty-five years, attaining the grade of Admiral in October 1988. His sea commands included a Guided Missile Cruiser, two Destroyer Squadrons, and a Cruiser- Destroyer Flotilla. He commanded the U.S. Seventh Fleet from May 1983 - March 1985.
Admiral Hogg, in addition to the U. S. Naval Academy, is a graduate of the U.S. Air Force Command and Staff College and holds a degree of Master of Science in Business Administration at George Washington University.
Job Titles:
- Scientific Advisor
- Physician at Massachusetts General Hospital
Dr. Gelfand is a Physician at Massachusetts General Hospital (MGH) and Clinical Professor of Medicine at Harvard Medical School. He also holds an appointment as Professor of Medicine at Tufts University School of Medicine.
For two years he served as Dean for Research at Tufts University School of Medicine and Senior Vice President for Research and Technology at Tufts- New England Medical Center. Dr. Gelfand was Professor and Chairman of the Department of Medicine of Tufts University School of Medicine and Physician-in-Chief at Tufts- New England Medical Center.
Dr.Gelfand has conducted laboratory and clinical research in immunology, inflammation, infection for over 30 years, with more than 90 peer-reviewed scientific publications and 50 chapters in leading textbooks of medicine. Most recently, Dr. Gelfand's research interests have focused on vaccines for infectious diseases and cancer therapeutics. He founded programs for the Center for Integration of Medicine and Innovative Technology (www.CIMIT.org), which develops solutions to medical problems by fostering collaboration between engineers and physicians. At MGH he co-founded a company to develop methods to enhance immune responses to vaccines, a therapeutic vaccine targeting ovarian cancer, and a vaccine platform to enable rapid and/or personalized vaccines for cancers or infectious diseases.
In 2007, Dr. Gelfand was elected a Fellow of American Association for the Advancement of Science "for distinguished contributions to clinical immunology and vaccine development."
He has consulted for the US Department of Homeland Security.
Job Titles:
- Chief Administrative Officer
Mr. Pacheco was born and raised in New York City, receiving medals in mathematics and science early on in his education which formed his desire to work with people and numbers.
In 1989, Mr. Pacheco founded an international accounting and financial management firm, Pacheco & Associates, which advises small, medium and large size businesses in Fortune 500 consulting, management techniques, and expertise. Prior to forming his own firm, Mr. Pacheco was in the International Corporate Finance Division of Manufacturers Hanover Trust, Bank of Montreal, and Sumitomo. He has worked on numerous leverage buyouts, corporate debt financings /restructurings, mergers and acquisitions, and IPOs some of which were featured in books and novels. His firm also has been active in helping start-up companies. The Firm's clientele includes the US, Latin American, Asian and European corporations.
Mr. Pacheco served on the advisory board of the Lower East Development Corporation and advisor to the Urban Development Corporation under the Mario Cuomo administration of NYS.
Mr. Pacheco and his firm also have developed programs to help Women and Minorities start their own business and become effective financial managers. His program has been attended by more than 2500 Women and Minority entrepreneurs looking for a way to integrate and/or develop a business dream. He has also provided services for not for profit organizations. He received the first award from the Puerto Rican National Day parade for his outstanding leadership in finance, and the programs for women and the minority community.
Mr. Pacheco was also the recipient of the prestigious Citibank award in finance and accounting. His hobbies, interest, and sports include Chess, Golf, Traveling, and Skiing.
Job Titles:
- Member of the Advisory Committee
Mr. French has been a venture capitalist for 50 years and has been involved in an extensive portfolio of predominately early stage national and international companies. During that period he was President of Research & Science Investors Inc. and internationally was involved in operations in China, Korea and Europe.
He has been a Director of OSI Pharmaceutical and several private companies and was a trustee of the Newport Preservation Society.
Mr. French has a BS from Yale and a JD from the Harvard Law School. His early career was in US Naval Intelligence.
Job Titles:
- Member of the Board of Directors
- Partner
Mr. White is a partner in the law firm Cooper & Dunham LLP that specializes in intellectual property law.
Mr. White's law practice primarily focuses on the areas of pharmaceuticals, biotechnology, and medical devices representing corporations, start-up ventures and university research centers in counseling, patent prosecution, licensing and litigation.
Mr. White has served on the boards of directors of a number of successful start-up ventures, which became public companies, including Bio-Technology General Corporation (now Savient Pharmaceuticals), IGEN, Inc. (acquired by Roche), TCell Sciences, Inc. (acquired by Biogen/Idec), and OSI Pharmaceuticals, Inc., which was recently acquired by Astellas.
Mr. White attended Columbia University School of Engineering, where he earned a B.S. degree in chemical engineering, and Columbia University's School of Graduate Arts and Sciences where he earned an M.A. degree in chemical biology and a M.Ph. degree in biophysical chemistry. Mr. White also received a J.D. degree from Fordham University.
Job Titles:
- Member of the Advisory Committee
Mr. Manning was Chairman of the UK Board for Health and Social Care Information Centre 2013-2016. HSCIC (now NHS Digital) has a pivotal new role as the focal point for data and for core IT infrastructure and expertise across the health and care system playing a fundamental role in driving better care, services and outcomes as part of the UK Government's reforms under the Health and Social Care Act 2012.
Kingsley was Founder and Managing Director of Newchurch Limited, a firm of health, medical tech & information consultants, from 1983 until 2009 and again from June 2016.
He became Executive Chairman of Tribal Group's health business and Senior Adviser at McKinsey & Company 2009-13.
He is a Visiting Professor of the Management School, Imperial College, London, and acted as a Special Advisor to the House of Commons Select Committee on Healthcare, the Transport Select Committee and the National Audit Office.
Dr. Corrigan was Executive Vice President of Research and Development at the specialty pharmaceutical company Sepracor Inc., and prior to this, he spent 10 years with Pharmacia & Upjohn, most recently as Group Vice President of Global Clinical Research and Experimental Medicine.
Before entering the healthcare industry, Dr. Corrigan was in academic research at the University of North Carolina at Chapel Hill School of Medicine, where he maintains a faculty appointment as Adjunct Professor in the Psychiatry Department.
Dr. Corrigan served on the Board of Directors for Cubist Pharmaceuticals and of Avanir Pharmaceuticals prior to their acquisitions by Merck and Otsuka Holdings, respectively, and served as chairman of EPIRUS Biopharmaceuticals' Board.
Dr. Corrigan holds an M.D. degree from the University of Virginia and received specialty training in psychiatry at Maine Medical Center and Cornell University.
Job Titles:
- Member of the Advisory Committee
Mr. van Lennep currently serves on the Non-Executive Board of: WMPartners in Zurich (subsidiary of the Julius Baer Group), Redhead Family Corporation (Odesssa, Ukraine) and as a member of advisory boards of a number of wealth management firms, families and family foundations in Argentina, Bermuda, the Netherlands, Russia, Singapore, Switzerland and the UK.
He is a former guest speaker at the Insead Business School (Paris, Singapore) at the ABNAMRO Global Private Banking Certification Program and the ICICI Bank (India) Client Education Forum.
Mr. van Lennep is a former Managing Director and CEO of ABN AMRO Bank Switzerland and Global Head International private banking. Mr. van Lennep started his career at Chase Manhattan Bank in New York. He subsequently worked with JP Morgan in Amsterdam and London in corporate and structured finance. After that he held a number of international postings with ABN AMRO Bank in Hong Kong (Deputy CEO), Taiwan (CEO) and the UK (CEO).
He is a graduate of the Leiden University Law School in the Netherlands and served in the Dutch Military Intelligence Service.
Job Titles:
- Member of the Board of Directors
Struan Coleman MD, PhD, is a world-renowned, board-certified orthopedic surgeon specializing in hip preservation and sports medicine at Hospital for Special Surgery in New York City and the Vincera Institute in Philadelphia.
Dr. Coleman earned a medical degree from Columbia College of Physicians and Surgeons and holds a D.Phil in Microbiology from Oxford University, England. He completed both his residency in Orthopedic Surgery and a fellowship in Sports Medicine at the Hospital for Special Surgery. During his fellowship, Dr. Coleman worked as an assistant physician for the New York Giants football team and is currently the Head Team Physician for the New York Mets baseball team.
Dr. Coleman focuses on the treatment and management of sports related injuries of the hip, knee, and shoulder, with a particular interest in hip arthroscopy and hip preservation. In his practice, he treats young, athletic patients with hip pathology; in addition, he has performed arthroscopic surgery on many high level athletes with hip problems, including NFL players from the Green Bay Packers, Oakland Raiders, and Washington Red Skins.
Dr. Coleman also combines his clinical practice with research relating to the fields of hip arthroscopy and sports medicine, and he has published numerous articles and written chapters in those fields. Dr. Coleman holds numerous patents for technologies that are utilized by sports medicine physicians and surgeons. Most recently, he patented the technology behind the CyMedica QB1 Rehabilitation System, which is used to treat quadriceps atrophy. Dr. Coleman is the founder of CyMedica Orthopedics and he is on the board of the company.
Job Titles:
- Member of the Board of Directors
A member of the Council on Foreign Relations and the Infantry Order of St. Crispin, Mr. West has served on the board of trustees of the Manlio Brosio Center in Rome and the Center for Naval Analyses in Virginia. He is the recipient of the Department of Defense Distinguished Public Service Medal, the 2004 and the 2012 Marine Corps Heritage Award, the Colby Military History Award, the Marine Corps Foundation Award for Leadership, the Goodpaster Prize for Military Scholarship, Tunisia's Medaille de Liberté, the Father Clyde Leonard Award, the Free Press Award, the Marine Corps Combat Correspondents Award and the Veterans of Foreign Wars National Media Medal.
Other posts he has held include: analyst at the Rand Corporation, visiting professor at Tufts University, Assistant to the Secretary and Deputy Secretary of Defense, Vice President of the Hudson Institute and Dean of Research at the Naval War College.
He served in Vietnam as an infantry captain and was a member of the Marine Force Reconnaissance team that initiated Operation Stingray - attacks deep behind enemy lines.
Mr. West served as Assistant Secretary of Defense for International Security Affairs in the Reagan administration.
He has also served as an adviser to the commander of the US Central Command. He has embedded dozens of times with our troops in Iraq and Afghanistan and written several best-selling military histories. Mr. West's articles appear in The Wall St. Journal, The New York Times, The Atlantic, The National Review, Foreign Affairs Magazine and The Washington Post. He also appears on The News Hour and Fox News.
A graduate of Georgetown ('61) and Princeton ('67) Universities, Mr. West also studied in Switzerland and was a Woodrow Wilson Fellow at Princeton.
Job Titles:
- Member of the Advisory Committee
Mr. Mehta brings a wide-ranging global health care perspective to pharmaceutical and biotechnology asset management, investment research, and strategic advice.
Mr. Mehta's work with the international division of Merck & Co. involved international strategic planning and competitor analysis. This global foundation prompted Wood MacKenzie & Company Inc. to invite him to establish a pharmaceutical research function in New York. This effort was expanded at S.G. Warburg & Company Inc. and led to the formation of his own advisory group, Mehta and Isaly.
Now known as Mehta Partners, the group provides strategic advisory, asset management, and institutional research services to clients worldwide. Mehta Partners have honed a specialty niche with an integrated global perspective aimed at understanding the critical success factors in the worldwide pharmaceutical and biotechnology sector, where for over 25 years, Mr. Mehta has advised senior managers and investors to capitalize upon emerging opportunities.
Mr. Mehta is a former Director at OSI Pharmaceuticals.
Educated at the University of Southern California (PharmD) and UCLA (MBA in international finance and marketing), he has worked with the pharmaceutical and biotechnology industry as well as private and public health care providers.
Job Titles:
- Member of the Advisory Committee
- President of Teagle Management Company
Mr. Teagle is the President of Teagle Management Company, a private investment consulting firm. He also serves as a Director, Trustee and/or advisor to a number of philanthropic organizations.
Previously he was the Founder and General Partner of Groton Partners, a small merchant banking firm. Over the last 25 years he has been a Founder, Director and Officer of several entrepreneurial companies. He started his investment career at Exxon Mobil Corporation in the Treasurer's Office. After attending graduate school he became a portfolio manager at Brown Brothers Harriman & Co. He currently serves as the Non-Executive Chairman of the First National Bank of Long Island as well as the Chairman of the Board of the Teagle Foundation.
He graduated from the University of Maryland with a Bachelor of Science degree in economics and received a Masters in Business Administration from the Wharton School at the University of Pennsylvania.